Pacira Pharmaceuticals reported $228.69M in Current Liabilities for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acelrx Pharmaceuticals ACRX:US $ 15.19M 0.36M
Adamas Pharmaceuticals ADMS:US 21.82M 7.35M
Aerie Pharmaceuticals AERI:US $ 108.09M 14.72M
Amerisourcebergen ABC:US $ 39589.84M 6593.39M
Antares Pharma ATRS:US $ 71.97M 0.17M
Astellas Pharma 4503:JP Y 581580M 10792M
Biodelivery Sciences International BDSI:US $ 63.91M 9.32M
Bristol Myers Squibb BMY:US $ 18991M 1661M
Cara Therapeutics CARA:US $ 15.17M 1.35M
Coherus Biosciences CHRS:US $ 287.05M 29.45M
Depomed DEPO:US $ 116.91M 7.82M
Endo International Ordinary Shares ENDP:US $ 1409.21M 13.72M
Flexion Therapeutics FLXN:US $ 39.93M 18.05M
Heron Therapeutics HRTX:US $ 82.14M 18.77M
Horizon Pharma HZNP:US $ 852.81M 78.97M
Ironwood Pharmaceuticals IRWD:US $ 134.37M 110.77M
JAZZ PHA JAZZ:US $ 880.59M 128.5M
Lannett LCI:US $ 90.47M 6.66M
Ligand Pharmaceuticals LGND:US $ 52.5M 43.31M
Nektar Therapeutics NKTR:US $ 131.02M 7.39M
Omeros OMER:US $ 47.7M 4.26M
Pacira Pharmaceuticals PCRX:US $ 228.69M 3.39M
Perrigo Ordinary Shares PRGO:US $ 1984.5M 537.7M
Revance Therapeutics RVNC:US $ 58.25M 7.41M
Supernus Pharmaceuticals SUPN:US $ 283.45M 42.64M
Teva Pharmaceutical TEVA:IT 12.69B 602M
Xeris Pharmaceuticals Inc XERS:US $ 35.46M 8.04M
Xoma XOMA:US $ 6.29M 6.82M
Zoetis ZTS:US $ 2091M 25M